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SummaryThis study evaluated the
feasibility of fiducials as a
surrogate for gross tumor
volume position in rectal
cancer. Setup correction
based on fiducials reduces
required margins in the
anterior-posterior and cra-
niocaudal directions for a
gross tumor volume boost
compared with bony anat-
omy setup correction.
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https://doi.org/10.1016/j.ijrobp.2019.08.052Purpose: To evaluate the feasibility of fiducial markers as a surrogate for gross tumor
volume (GTV) position in image-guided radiation therapy of rectal cancer.
Methods and Materials: We analyzed 35 fiducials in 19 patients with rectal cancer
who received short-course radiation therapy or long-course chemoradiation therapy.
Magnetic resonance imaging examinations were performed before and after the first
week of radiation therapy, and daily pre- and postirradiation cone beam computed to-
mography scans were acquired in the first week of radiation therapy. Between the 2
magnetic resonance imaging examinations, the fiducial displacement relative to the
center of gravity of the GTV (COGGTV) and the COGGTV displacement relative to
bony anatomy were determined. Using the cone beam computed tomography scans,
inter- and intrafraction fiducial displacement relative to bony anatomy were deter-
mined.
Results: The systematic error of the fiducial displacement relative to the COGGTV was
2.8, 2.4, and 4.2 mm in the left-right, anterior-posterior (AP), and craniocaudal (CC)
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van den Ende et al. International Journal of Radiation Oncology  Biology  Physics1152may be higher in patients
with a proximal compared
with a distal tumor.random errors up to 4.7 mm were found for COGGTV and fiducial displacements rela-
tive to bony anatomy, mostly in the AP and CC directions. For tumors located in the
mid and upper rectum, these errors were up to 9.4 mm (systematic) and 5.6 mm
(random) compared with 4.9 mm and 2.9 mm for tumors in the lower rectum. System-
atic and random errors of the intrafraction fiducial displacement relative to bony anat-
omy were 2.1 mm in all directions.
Conclusions: Large interfraction errors of the COGGTV and the fiducials relative to
bony anatomy were found. Therefore, despite the observed fiducial displacement rela-
tive to the COGGTV, the use of fiducials as a surrogate for GTV position reduces the
required margins in the AP and CC directions for a GTV boost using image-guided ra-
diation therapy of rectal cancer. This reduction in margin may be larger in patients with
tumors located in the mid and upper rectum compared with the lower rectum.  2019
The Author(s). Published by Elsevier Inc. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Neoadjuvant radiation therapy reduces local recurrence
rates after surgery in patients with rectal cancer.1-4 A
pathologic complete response is observed in 15% to 25% of
patients after neoadjuvant chemoradiation.5,6 In addition,
dose escalation is suggested to result in higher complete
response rates, which is attractive considering the increased
interest in organ preservation.6-10
The current clinical practice for setup correction in
external beam radiation therapy of rectal cancer is based on
bony anatomy using cone beam computed tomography
(CBCT).11 To ensure proper gross tumor volume (GTV)
coverage in a GTV boost setting, a planning target volume
(PTV) margin of 7 to 30 mm is used to accommodate
delineation errors, setup errors, and inter- and intrafraction
motion of the GTV.12-16 Setup correction based on the GTV
instead of bony anatomy may decrease the required PTV
margins. However, this is challenging owing to the limited
soft tissue contrast of CBCT.17 Magnetic
resonanceeguided radiation therapy systems could be used
to perform setup correction based on a direct visualization
of the GTV with superior soft tissue contrast.18 However,
such systems are not widely available yet. Given that
fiducial markers have been proven useful for setup
correction in other tumor locations such as pancreas,
esophagus, and prostate,19-21 fiducials may be useful as a
surrogate for GTV position in rectal cancer. Several studies
have reported on the use of fiducials in the rectum and
focus on marker visibility and migration,22 fiducial reten-
tion and adverse events,23,24 and the use of fiducials to aid
in the delineation of the target volume.25 However, none
have investigated the potential benefit of fiducials for setup
correction in radiation therapy of rectal cancer.
To use fiducials as a surrogate for the GTV, the position
of the fiducials must be representative of the position of the
GTV. The aim of this study was therefore to evaluate the
feasibility of fiducials as a surrogate for GTV position in
radiation therapy of rectal cancer.Methods and Materials
Patients
Between July 2015 and September 2016, we included 20 pa-
tients with proven rectal adenocarcinoma who were scheduled
for short-course radiation therapy (5  5 Gy) or long-course
chemoradiation therapy (LC-CRT; 25  2 Gy combined with
capecitabine 825 mg/m2 twice daily on days of radiation
therapy) followed by total mesorectal excision. Patients were
treated in supine position. Before each radiation therapy
fraction, patients were asked to void their bladder and subse-
quently drink 300 cm3 of water to reproduce bladder filling.
Exclusion criteria were contraindication for fiducial inser-
tion (coagulopathy or anticoagulantia that could not be
stopped), prior pelvic irradiation, pelvic surgery or hip
replacement surgery, pregnancy, a contraindication for mag-
netic resonance imaging (MRI), or World Health Organization
performance status 3 to 4. This study was registered at the
Dutch Trial Registry (REMARK study, registration no.
NL4473).26
Fiducials
We used 4 types of fiducials, inserted in 5 patients each
(Visicoil 0.5 x 5 mm and Visicoil 0.75 x 5 mm [IBA
Dosimetry, GmbH, Germany], Cook 0.64 x 3.4 mm [COOK
Medical, Limerick, Ireland], and Gold Anchor 0.28 x 20
mm [unfolded length][Naslund Medical AB, Sweden]). We
endoscopically placed the fiducials in the tumor and mes-
orectum at least 1 day before the start of radiation therapy.
The fiducial insertion strategy is described in Rigter et al.24
MRI processing
We performed 2 multiparametric MRI examinations for each
patient on a Philips Achieva 1.5T, Philips Achieva 3T, Phi-
lips Achieva dStream 3T, or Philips Ingenia 3T. Details of
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(available online at https://doi.org/10.1016/j.ijrobp.2019.08.
052). We acquired a first MRI examination up to 2 weeks
before or up to 1 week after the start of radiation therapy and
a second MRI examination between 1 and 2 weeks after the
start of radiation therapy. In an earlier study, we evaluated
the MRI visibility of the fiducials, and we identified 17 out
of 34 fiducials on the first MRI and 9 out of 30 fiducials on
the second MRI.27 The Visicoil 0.75 and the Gold Anchor
were the best visible fiducials on MRI. In addition, a
consensus meeting with a radiologist (EP) and a resident
radiation oncologist (ER) was held to identify more fiducials
for this study. We delineated the artefacts that the fiducials
created on MRI on the tT2-TSE scan with help of the other
available sequences. The coordinate of the center of gravity
(COG) of this delineation represented the fiducial position.
The GTV was delineated on the tT2-TSE scan of both MRI
examinations by1observer (RE)andwas subsequently checked
by a radiation oncologist (FP) in Oncentra (Elekta, Veenendaal,
Netherlands). We registered the tT2-TSE sequence of the sec-
ondMRI examination to the tT2-TSE sequence of the firstMRI
examination using Elastix28 with a rigid transformation based
on the bony anatomy of the pelvis and the sacrum.
We selected both ischial spines and the pubic symphysis
as anatomic landmarks on the bony anatomy on the MRI
examinations to assess registration accuracy. The registra-
tion accuracy was defined as the mean and standard devi-
ation of the distances between a landmark position on the
registered second MRI examination and the corresponding
landmark position on the first MRI examination.
To determine the displacement of the fiducials relative to
the GTV, we calculated the displacement for each fiducial
relative to the center of gravity of the GTV delineation
(COGGTV) on the second MRI with respect to the first MRI.
Subsequently, we determined the mean of means by
calculating the mean displacement over all fiducials and the
group systematic error by calculating the standard deviation
over all fiducial displacements.29
To determine the interfraction GTV displacement relative to
bony anatomy, we calculated the displacement of the COGGTV
relative to bony anatomy on the second MRI with respect to the
first MRI. Subsequently, we determined the mean of means by
calculating the mean displacement over all COGGTV displace-
ments and the group systematic error by calculating the stan-
dard deviation over all COGGTV displacements.
29
To test for differences indisplacementbetweenproximal and
distal tumors, we calculated the interfraction COGGTV
displacement relative to bony anatomy on MRI separately for
patients with a tumor in the mid and upper rectum (7-16 cm
from anal verge) and the lower rectum (0-6 cm from anal
verge).30CBCT processing
During the first week of radiation therapy, we acquired
daily pre- and postirradiation CBCT scans (Elekta XVI,reconstructed slice thickness 1.0 mm, pixel spacing 1.0 mm
 1.0 mm). For the patients who were treated with LC-
CRT, preirradiation CBCT scans were acquired weekly
after the first week of radiation therapy.
The first preirradiation CBCT scan was used as the
reference scan. We registered all subsequent CBCT scans to
the reference scan using Elastix with a rigid registration
based on the bony anatomy of the pelvis and the sacrum.28
The registration accuracy was assessed using the same
method as described for the MRI examinations, with the
promontory as an additional anatomic landmark.
We segmented fiducials on the reference and registered
CBCT scans by manually selecting a point on each fiducial.
A box of 12  12  12 mm was automatically created
around each selected point, and a threshold that was well
above the image intensities of the surrounding soft tissue
was applied to segment the fiducial. The coordinate of the
COG for each fiducial segmentation was used as the posi-
tion for each fiducial.
The displacement of the COG of all fiducials (COGFID)
as a result of changes in fiducial configuration was calcu-
lated as follows. For patients with 2 or more fiducials in
situ, the position of each fiducial relative to the COGFID
was determined on each preirradiation CBCT scan. To
assess the resulting displacement of the COGFID, we
calculated the standard deviation of each fiducial position
relative to COGFID over all preirradiation CBCT scans
(SDFID) and subsequently calculated the standard deviation
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with SD2FID1 , SD
2
FID2
, ., SD2FIDnbeing the squared standard
deviation of a fiducial position relative to COGFID over all
preirradiation CBCT scans in the patient and n being the
number of fiducials in the patient. Subsequently, we
determined the group random error by calculating the root
mean square of all the standard deviations of COGFID.
29
To determine the interfraction fiducial displacement
relative to bony anatomy, we calculated the displacement of
each fiducial on each preirradiation CBCT scan with
respect to the reference scan. To determine the intrafraction
fiducial displacement relative to bony anatomy, we calcu-
lated the displacement of each fiducial on the post-
irradiation CBCT scan with respect to the preirradiation
CBCT scan of the same fraction. For each fiducial, we
calculated a mean displacement and corresponding stan-
dard deviation over all fractions for the inter- and
intrafraction displacement in the left-right (LR), anterior-
posterior (AP), and craniocaudal (CC) directions.
Subsequently, we calculated for the inter- and intrafraction
fiducial displacement the mean of means over all fiducials
and the group systematic and random error by calculating
the standard deviation of the mean displacements of all
fiducials and the root mean square of the standard deviation
of all fiducials.29
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and distal tumors, we calculated the interfraction fiducial
displacement relative to bony anatomy separately for pa-
tients with a tumor in the mid and upper rectum (7-16 cm
from anal verge) and the lower rectum (0-6 cm from anal
verge).30
Treatment margins
To determine PTV margins, we quadratically added sys-
tematic and random errors of the different components to
derive the combined errors for the GTV position in 3 image
guidance scenarios using the Van Herk et al margin
recipe.31 For setup correction based on bony anatomy, the
inter- and intrafraction displacement of the GTV relative to
the bony anatomy needs to be considered. We derived the
interfraction displacement relative to bony anatomy in 2
ways: first, from the COGGTV displacement on MRI, and
second, from the fiducial displacements on CBCT. Both
were combined with the intrafraction fiducial displacement
on CBCT to calculate the errors for setup correction based
on bony anatomy. In a scenario of setup correction based on
fiducials, we also need to consider the position uncertainty
of the GTV relative to the fiducials. Therefore, we com-
bined the fiducial displacement relative to the COGGTV
with the COGFID displacement as a result of changes in
fiducial configuration and the intrafraction fiducial
displacement relative to bony anatomy on CBCT. In a
scenario in which the GTV can be visualized directly for
setup correction, we only used the errors of the intrafraction
fiducial displacement relative to bony anatomy.
Statistical analysis
We used SPSS Statistics 23 (IBM Corp. Released 2015.
IBM SPSS Statistics for Windows, version 23.0. Armonk,
NY) for statistical analysis. Because of the small sample
size in this study, we used the nonparametric
ManneWhitney U test to test for differences between the
mean and standard deviation of the fiducial displacements
according to the distance from the anal verge.
Results
Patients and fiducials
One patient was excluded because all fiducials were inad-
vertently inserted in the prostate. Therefore, 19 patients were
available for analysis, of whom 8 received short-course ra-
diation therapy and 11 received LC-CRT. Patient character-
istics are shown in Table 1. The fiducial retention in the
REMARK study was described earlier.24 A total of 35 fi-
ducials in situ were available for analysis on CBCT, of which
26 fiducials were in the tumor and 9 were in the meso-
rectum.27 The consensus meeting resulted in 22 identified
fiducials on the first MRI and 17 identified fiducials on thesecond MRI. All 17 fiducials identified on the second MRI
were also identified on the first MRI. Of those, 14 fiducials
were inserted in the tumor and 3 fiducials were inserted in
the mesorectum. Examples of a GTV delineation and a
fiducial on the T2-TSE sequence of both MRI examinations
and a fiducial on 2 CBCT scans is shown in Figure 1.Imaging
Median time from the first MRI to the start of radiation
therapy was 0 days (range, -5 to 12 days). Median time
between the first and second MRI examination was 7 days
(range, 4-21 days). For 2 patients who were treated with LC-
CRT, the first MRI examination was acquired 2 days
(2 fractions) and 5 days (3 fractions) after start of radiation
therapy. The median delineated GTV volume was 22.8 cm3
(range, 6.9-64.6 cm3) for the first MRI and 15.2 cm3 (range,
6.1-71.0 cm3) for the second MRI. Median difference be-
tween the GTV volumes of the first and second MRI was
-3.0 cm3 (range, -26.5 to 6.4 cm3), with a negative difference
indicating a smaller volume in the second MRI. Fourteen out
of 19 delineated GTV volumes were smaller on the second
MRI. The MRI registration error was on average 0.0 0.6 mm
(LR), 0.2  1.4 mm (AP), and -0.1  1.3 mm (CC).
A total of 219 CBCT scans were acquired in 19 patients
(range, 2-21 per patient), of which 132 were preirradiation
CBCT scans in 19 patients and 87 were postirradiation
CBCT scans in 17 patients. The average time between pre-
and postirradiation CBCT scans was 9  1 minutes. The
CBCT registration error was on average e0.1  0.7 mm
(LR), e0.2  0.9 mm (AP), and 0.0  0.8 mm (CC).Inter- and intrafraction displacement
The systematic error of the interfraction fiducial displace-
ment relative to the COGGTV was 2.8 mm (LR), 2.4 mm
(AP), and 4.2 mm (CC) as shown in Table 2. The random
error of the interfraction displacement of the COGFID was
<1 mm in all directions.
The systematic error of the COGGTV displacement
relative to bony anatomy was substantially larger than the
systematic error of the fiducial displacement relative to
bony anatomy on CBCT in the AP (7.2 mm vs 4.8 mm) and
CC direction (8.0 mm vs 4.6 mm). This was mainly due to
2 patients who showed large COGGTV displacements on
MRI in the AP and CC directions: 15 mm and -20 mm
(AP), and -16 mm and 20 mm (CC), respectively. After
reviewing the MRI examinations, we observed a large
difference in the amount of air in the rectum, which dis-
placed the GTV. In one of these patients, a large difference
in bladder filling was also observed. In the other 17 pa-
tients, the group systematic error of the COGGTV
displacement relative to bony anatomy was 4.1 mm (AP)
and 5.6 mm (CC), in line with the fiducial displacement
relative to bony anatomy on CBCT.




























1 M 71 T3N0M0 5 SC-RT Visicoil 0.5 5 5 3 1 1
2 M 82 T3N0M0 0 SC-RT Visicoil 0.5 5 4 3 2 1
3 M 63 T2N0M0 2 LC-CRT Visicoil 0.5 10 4 3 1 0
4 M 60 T3N1M0 8 LC-CRT Visicoil 0.5 10 4 3 3 0
5 F 60 T3N1M0 2 SC-RT Visicoil 0.5 2 0 3 1 1
6 M 67 T3N2M0 8 LC-CRT Visicoil 0.75 10 6 3 1 1
7 F 52 T3N1M0 8 SC-RT Visicoil 0.75 5 0 3 2 0
8 M 75 T3N0M0 10 SC-RT Visicoil 0.75 4 2 3 2 2
9 M 82 T2N1M0 15 SC-RT Visicoil 0.75 5 5 3 1 1
10 M 63 T3N1M0 15 SC-RT Visicoil 0.75 5 5 3 1 1
11 F 62 T2N1M0 11 SC-RT COOK 5 5 3 2 0
12 M 58 T3N0M0 1 LC-CRT COOK - - 4 - -
13 M 57 T3N2M0 7 LC-CRT COOK 10 5 4 1 1
14 F 60 T3N1M0 2 SC-RT COOK 5 5 4 3 0
15 M 59 T3N2M0 8 LC-CRT COOK 11 8 4 3 0
16 M 63 T3N0M0 1 LC-CRT Gold Anchor 9 5 3 2 2
17 M 65 T3N2M0 2 LC-CRT Gold Anchor 9 5 3 1 1
18 M 59 T2N1M0 16 SC-RT Gold Anchor 5 5 3 2 2
19 F 61 T3N1M0 10 SC-RT Gold Anchor 5 5 3 3 1
20 M 51 T3N0M0 2 LC-CRT Gold Anchor 12 9 3 3 2
Total 132 87 64 35 17
Abbreviations: CBCT Z cone beam computed tomography; cTNM Z clinical TNM; F Z female; M Z male; MRI Z magnetic resonance imaging;
Tx Z treatment schedule; SC-RT Z short-course radiation therapy; LC-CRT Z long-course chemoradiation therapy.
* Excludes fiducials that were inadvertently inserted in the prostate.
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bony anatomy, the systematic error was 3.0 mm (LR), 8.7
mm (AP), and 9.4 mm (CC) for patients with a tumor in the
mid or upper rectum, whereas it was 1.3 mm (LR), 4.7 mm
(AP), and 4.9 mm (CC) for patients with a tumor in the
lower rectum. Similarly, for the interfraction fiducial
displacement relative to bony anatomy on CBCT, system-
atic and random errors were 3.8 and 3.4 mm (LR), 6.1 and
5.1 mm (AP), and 5.5 and 5.6 mm (CC), respectively, for
the mid and upper group and 3.1 and 1.1 mm (LR), 1.6 and
2.3 mm (AP), and 2.8 and 2.9 mm (CC), respectively, for
the lower-rectum group. The standard deviation of the
interfraction fiducial displacements relative to bony anat-
omy was significantly higher for patients with a tumor in
the mid or upper rectum compared with patients with
a tumor in the lower rectum in the LR (P < .01), AP
(P Z .03), and CC (P Z .04) directions. An overview of
the inter- and intrafraction fiducial displacements relative to
bony anatomy split according to tumor location is shown in
Figure 2 and Figure 3.
Systematic and random errors of the intrafraction fidu-
cial displacement relative to bony anatomy were 2.1 mm
in all directions.Setup correction scenarios
For setup correction based on bony anatomy, the estimated
margins were 8.3 mm (LR), 19.5 mm (AP), and 21.9 mm
(CC) using the COGGTV displacement relative to bony
anatomy and 11.3 mm (LR), 15.7 mm (AP), and 15.8 mm
(CC) using the fiducial displacement relative to bony
anatomy (Table 3). For setup correction based on fiducials,
a reduction to 8.3 mm (LR and AP) and 12.8 mm (CC) was
observed. Setup correction based on a direct visualization
of the GTV would further reduce required margins to 3.0
mm (LR), 4.7 mm (AP), and 5.5 mm (CC).Discussion
The aim of this study was to evaluate the feasibility of fi-
ducials as a surrogate for GTV position in rectal cancer.
Despite fiducial displacement relative to the COGGTV, an
advantage for fiducial setup correction was observed in the
AP and CC directions compared with bony anatomy setup
correction. Consequently, the use of fiducials in a GTV boost
setting allows for more precise irradiation of the GTV and
Fig. 1. (A) and (B) examples of a gross tumor volume delineation and a fiducial on the T2-TSE sequence of both magnetic
resonance imaging examinations and (C) and (D) the same fiducial on 2 preirradiation cone beam computed tomography
scans for patient 19.
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rectum compared with the distal rectum is reported.32-34
Although only a small number of patients were included in
our study, a similar difference was observed. This suggests
that the advantage of setup correction based on fiducials may
be larger in patients with a proximal tumor.
The interfraction systematic error of the COGGTV rela-
tive to bony anatomy, as based on MRI, was substantially
larger than the systematic and random errors of the fiducial
displacements on CBCT. This is mainly due to large
displacement of the COGGTV in 2 patients on MRI and may
be explained by the absence of patient preparation before
the MRI examinations. For the calculation of the
displacement of the COGFID as a result of changes in
fiducial configuration, the COGFID was used as a reference
point, assuming that all fiducials contributed equally to
changes in fiducial configuration.
There is an inherent inaccuracy in determining exact
fiducial locations on MRI, for instance due to the asym-
metrical artefacts of the fiducials.35 With help of the other
available sequences, we delineated the fiducials on the tT2-
TSE scan because it had the smallest artifacts.27 Therefore,we believe that the inaccuracy in selecting the exact fiducial
location has a minor effect on the observed fiducial dis-
placements on MRI.
In the last 2 decades, organ motion in patients with rectal
cancer has been actively investigated, and most studies
focus on the movement of the clinical target volume rela-
tive to bony anatomy.11,32,33,36-38 Only a few papers have
investigated the position variability of the GTV to deter-
mine the required margins for a GTV boost. Kleijnen et al
studied the motion of the rectum and GTV based on
repeated MRI data.39-41 They evaluated the intra- and
interfraction displacement of the GTV relative to bony
anatomy on time intervals of 1 minute, 9.5 minutes, 18
minutes, and 1 to 4 days using daily MRI examinations in
16 patients. They report a required margin of around 8 mm
in all directions for both the 9.5-minute and 1- to 4-day
timepoints.33 However, a direct comparison is difficult
because they used a different method to calculate the dis-
placements and corresponding margins, and they did not
report the tumor location for each patient.
Furthermore, Kleijnen et al report that although setup
errors based on the rectal wall were slightly reduced
Table 2 Mean of means, systematic error, and random error for the different analyses
LR, mm AP, mm CC, mm Available data
Position uncertainty of GTV w.r.t. fiducials
Interfraction displacement fiducials
w.r.t. COGGTV (MRI)
M 0.9 0.5 0.2 MRI scans 26
S 2.8 2.4 4.2 Fiducials 17
s - - - Patients 13
Interfraction displacement of
COGFID as a result of changes in
fiducial configuration (CBCT)
M - - - CBCT scans 76
S - - - Fiducials 27
s 0.6 0.9 0.9 Patients 11
Interfraction displacement w.r.t. bony anatomy
Interfraction displacement of
COGGTV (MRI)
M 0.2 0.5 1.2 MRI scans 38
S 2.8 7.2 8.0 Patients 19
s - - -
Interfraction displacement of
fiducials (CBCT)
M 0.4 2.7 1.2 CBCT scans 132
S 3.6 4.8 4.6 Fiducials 35
s 2.7 4.2 4.7 Patients 19
Intrafraction displacement w.r.t. bony anatomy
Intrafraction displacement of
fiducials (CBCT)
M 0.1 0.5 1.1 CBCT scans 87
S 0.8 1.4 1.6 Fiducials 32
s 1.4 1.7 2.1 Patients 17
Abbreviations: AP Z anterior-posterior; CBCT Z cone beam computed tomography; CC Z craniocaudal; COG Z center of gravity; FID Z fiducial;
GTV Z gross tumor volume; LR Z left-right; M Z mean of means; MRI Z magnetic resonance imaging; S Z systematic error; s Z random error.
Volume 105  Number 5  2019 Rectum GTV boost using fiducials 1157compared with bony anatomy, a similar PTV margin was
found. More importantly, the rectal wall could not be used
as a surrogate for the GTV position because displacement
of the rectal wall and the GTV along the direction of the
rectal wall will not be detected owing to the absence of
anatomic landmarks on the rectal wall.40 They conclude
that to further reduce uncertainties in a GTV boost setting,
direct or indirect online tumor visualization is needed. In
our study, we have shown that fiducials as an indirect
visualization of the GTV reduces uncertainties. However,
an uncertainty of the GTV position relative to the fiducials
remains.
The suggested margins for setup correction based on
bony anatomy as reported by Kleijnen et al41 are lower thanTumor in lower rectum



















Fig. 2. Boxplots of the interfraction fiducial displace-
ments relative to bony anatomy on cone beam computed
tomography in the left-right, anterior-posterior, and cra-
niocaudal directions, split according to tumor location.those in our study, especially in the AP direction. However,
a direct comparison is difficult because they did not report
on the tumor location or intrafraction displacement of the
tumor. Brierley et al assessed the interfraction displacement
of the rectum, mesorectum, and GTV relative to bony
anatomy.34 They found that GTV displacement was greatest
in the CC direction, which is confirmed by the results in our
study.
A limitation of the use of fiducials might be the low
retention rate. In our study, a total of 64 fiducials were
inserted, of which 35 fiducials were still in situ at the end of
radiation therapy.24 Furthermore, the insertion of fiducials
is an invasive procedure. Previous studies on fiducial
insertion in the rectum report no serious adverseTumor in lower rectum



















Fig. 3. Boxplots of the intrafraction fiducial displace-
ments relative to bony anatomy on cone beam computed
tomography in the left-right, anterior-posterior, and cra-
niocaudal directions, split according to tumor location.
Table 3 Systematic error, random error, and corresponding
margin for different setup correction scenarios
LR, mm AP, mm CC, mm
Setup correction based on bony anatomy (COGGTV MRI data)
S 2.9 7.3 8.2
s 1.4 1.7 2.1
Margin 8.3 19.5 21.9
Setup correction based on bony anatomy (fiducial CBCT data)
S 3.7 5.0 4.9
s 3.0 4.5 5.1
Margin 11.3 15.7 15.8
Setup correction based on fiducials
S 2.9 2.8 4.5
s 1.5 1.9 2.3
Margin 8.3 8.3 12.8
Setup correction based on GTV
S 0.8 1.4 1.6
s 1.4 1.7 2.1
Margin 3.0 4.7 5.5
Abbreviations: AP Z anterior-posterior; CBCT Z cone beam
computed tomography; CCZ craniocaudal; COGZ center of gravity;
GTV Z gross tumor volume; LR Z left-right; MRI Z magnetic
resonance imaging; S Z systematic error; s Z random error.
van den Ende et al. International Journal of Radiation Oncology  Biology  Physics1158events.22,24,25 In one study, a small amount of bleeding that
resolved spontaneously was reported in 1 out of 54
patients.23
A limitation of this study is the small number of patients.
Therefore, the determined margins and the observed dif-
ference between proximal and distal tumors would need
confirmation in a larger study. Because only 3 fiducials in
the mesorectum were identified on both MRI examinations,
no conclusions can be drawn about fiducial displacement
with respect to the tumor between fiducials implanted in the
tumor and the mesorectum. Furthermore, we evaluated the
displacement of the fiducials relative to the GTV only for
the first week of radiation therapy. If fiducials would be
used for the full duration of a long-course radiation therapy
schedule, the displacement of the fiducials relative to the
GTV should be investigated for all 5 weeks. Owing to
logistical reasons, the time between the MRI examinations
differed between patients. However, the difference is
mainly due to the time range of the first MRI examination
relative to the start of radiation therapy. Finally, the esti-
mated margins presented in this paper are based on the
position of the fiducials and GTV and do not include other
remaining errors involved in the treatment process.Conclusions
The results of this study show that despite the observed
fiducial displacement relative to the GTV, the use of fidu-
cials as a surrogate for GTV position reduces required
margins in the AP and CC directions for a GTV boost using
image guided radiation therapy of rectal cancer. Thereduction of required margins may be higher in patients
with a proximal compared with a distal tumor. However,
this needs to be confirmed in a larger study.References
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